105.26
price down icon0.75%   -0.80
after-market Handel nachbörslich: 105.42 0.16 +0.15%
loading
Schlusskurs vom Vortag:
$106.06
Offen:
$105.935
24-Stunden-Volumen:
7.49M
Relative Volume:
0.55
Marktkapitalisierung:
$261.26B
Einnahmen:
$63.90B
Nettoeinkommen (Verlust:
$19.05B
KGV:
13.92
EPS:
7.5596
Netto-Cashflow:
$13.05B
1W Leistung:
-1.12%
1M Leistung:
+0.41%
6M Leistung:
+32.97%
1J Leistung:
+5.81%
1-Tages-Spanne:
Value
$104.99
$106.10
1-Wochen-Bereich:
Value
$104.99
$107.59
52-Wochen-Spanne:
Value
$73.31
$107.59

Merck Co Inc Stock (MRK) Company Profile

Name
Firmenname
Merck Co Inc
Name
Telefon
908-740-4000
Name
Adresse
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Name
Mitarbeiter
75,000
Name
Twitter
@Merck
Name
Nächster Verdiensttermin
2025-02-04
Name
Neueste SEC-Einreichungen
Name
MRK's Discussions on Twitter

Vergleichen Sie MRK mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - General icon
MRK
Merck Co Inc
105.26 263.24B 63.90B 19.05B 13.05B 7.5596
Drug Manufacturers - General icon
LLY
Lilly Eli Co
1,074.68 966.40B 59.42B 18.41B 6.44B 20.22
Drug Manufacturers - General icon
JNJ
Johnson Johnson
206.95 498.51B 92.15B 25.12B 20.46B 10.36
Drug Manufacturers - General icon
ABBV
Abbvie Inc
228.49 406.04B 59.64B 2.36B 19.68B 1.3253
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
137.87 266.17B 54.45B 14.42B 17.15B 7.333

Merck Co Inc Stock (MRK) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-12-18 Hochstufung BMO Capital Markets Market Perform → Outperform
2025-11-24 Hochstufung Wells Fargo Equal Weight → Overweight
2025-11-13 Eingeleitet Scotiabank Sector Outperform
2025-10-13 Fortgesetzt Citigroup Neutral
2025-09-17 Herabstufung Berenberg Buy → Hold
2025-05-14 Herabstufung Citigroup Buy → Neutral
2025-04-22 Eingeleitet Cantor Fitzgerald Neutral
2025-02-18 Herabstufung Deutsche Bank Buy → Hold
2025-02-10 Herabstufung TD Cowen Buy → Hold
2025-01-08 Herabstufung Truist Buy → Hold
2024-12-20 Herabstufung BMO Capital Markets Outperform → Market Perform
2024-12-10 Fortgesetzt BofA Securities Buy
2024-12-04 Hochstufung HSBC Securities Hold → Buy
2024-11-15 Eingeleitet Wolfe Research Peer Perform
2024-11-11 Herabstufung Daiwa Securities Buy → Neutral
2024-10-17 Eingeleitet Bernstein Mkt Perform
2024-03-11 Herabstufung Societe Generale Hold → Sell
2024-01-04 Hochstufung TD Cowen Market Perform → Outperform
2023-11-09 Eingeleitet Deutsche Bank Buy
2023-10-27 Hochstufung BMO Capital Markets Market Perform → Outperform
2023-10-20 Hochstufung UBS Neutral → Buy
2023-07-14 Eingeleitet HSBC Securities Hold
2023-04-13 Hochstufung Citigroup Neutral → Buy
2023-03-28 Herabstufung Societe Generale Buy → Hold
2023-03-13 Herabstufung Wells Fargo Overweight → Equal Weight
2023-03-06 Eingeleitet Jefferies Buy
2023-02-22 Hochstufung Wolfe Research Peer Perform → Outperform
2023-01-04 Hochstufung BofA Securities Neutral → Buy
2022-11-18 Eingeleitet Credit Suisse Outperform
2022-10-10 Hochstufung Guggenheim Neutral → Buy
2022-09-14 Hochstufung Berenberg Hold → Buy
2022-07-06 Hochstufung Daiwa Securities Neutral → Buy
2022-06-06 Fortgesetzt SVB Leerink Outperform
2022-04-06 Fortgesetzt Morgan Stanley Equal-Weight
2021-12-17 Eingeleitet Goldman Buy
2021-12-16 Eingeleitet Daiwa Securities Neutral
2021-12-13 Herabstufung UBS Buy → Neutral
2021-12-09 Eingeleitet Wells Fargo Overweight
2021-12-07 Herabstufung Guggenheim Buy → Neutral
2021-11-29 Herabstufung Citigroup Buy → Neutral
2021-11-19 Eingeleitet BMO Capital Markets Market Perform
2021-11-01 Hochstufung Argus Hold → Buy
2021-09-07 Herabstufung Morgan Stanley Overweight → Equal-Weight
2021-07-27 Fortgesetzt Truist Buy
2021-05-20 Herabstufung Argus Buy → Hold
2021-04-07 Fortgesetzt RBC Capital Mkts Sector Perform
2020-11-10 Fortgesetzt Bernstein Outperform
2020-09-29 Eingeleitet Berenberg Hold
2020-08-03 Hochstufung Goldman Neutral → Buy
2020-06-12 Herabstufung Wolfe Research Outperform → Peer Perform
2020-02-27 Eingeleitet Barclays Overweight
2020-01-07 Eingeleitet RBC Capital Mkts Sector Perform
2019-10-17 Fortgesetzt BofA/Merrill Neutral
2019-08-16 Eingeleitet SVB Leerink Outperform
2019-07-03 Eingeleitet Mizuho Buy
2019-05-28 Eingeleitet Goldman Neutral
2019-05-13 Hochstufung Atlantic Equities Neutral → Overweight
2018-10-16 Bestätigt Citigroup Buy
2018-10-09 Fortgesetzt Guggenheim Buy
2018-04-23 Hochstufung Goldman Neutral → Buy
2018-04-17 Hochstufung Morgan Stanley Equal-Weight → Overweight
2018-04-05 Hochstufung Barclays Equal Weight → Overweight
2018-03-12 Hochstufung Leerink Partners Mkt Perform → Outperform
2018-02-14 Bestätigt Leerink Partners Mkt Perform
2018-02-07 Bestätigt Morgan Stanley Equal-Weight
2018-01-16 Hochstufung SunTrust Hold → Buy
Alle ansehen

Merck Co Inc Aktie (MRK) Neueste Nachrichten

pulisher
Dec 31, 2025

Merck stock dips after hours as 2025 ends; MRK investors shift focus to Feb. 3 earnings - ts2.tech

Dec 31, 2025
pulisher
Dec 31, 2025

Where is Merck & Co. (MRK) Headed? - Finviz

Dec 31, 2025
pulisher
Dec 31, 2025

JB Capital LLC Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat

Dec 31, 2025
pulisher
Dec 31, 2025

Los Angeles Capital Management LLC Buys 956,879 Shares of Merck & Co., Inc. $MRK - MarketBeat

Dec 31, 2025
pulisher
Dec 31, 2025

Stonebridge Financial Group LLC Has $638,000 Position in Merck & Co., Inc. $MRK - MarketBeat

Dec 31, 2025
pulisher
Dec 31, 2025

Sax Wealth Advisors LLC Increases Position in Merck & Co., Inc. $MRK - MarketBeat

Dec 31, 2025
pulisher
Dec 31, 2025

VIRGINIA RETIREMENT SYSTEMS ET Al Has $126.51 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat

Dec 31, 2025
pulisher
Dec 31, 2025

Smith Salley Wealth Management Reduces Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat

Dec 31, 2025
pulisher
Dec 31, 2025

Calamos Advisors LLC Lowers Holdings in Merck & Co., Inc. $MRK - MarketBeat

Dec 31, 2025
pulisher
Dec 31, 2025

Merck & Co., Inc. $MRK Shares Sold by 3Chopt Investment Partners LLC - MarketBeat

Dec 31, 2025
pulisher
Dec 30, 2025

FDA fast-tracks two Merck (MRK) drugs with blockbuster potential - MSN

Dec 30, 2025
pulisher
Dec 30, 2025

FDA Fast-Tracks Two Merck (MRK) Drugs With Blockbuster Potential - Finviz

Dec 30, 2025
pulisher
Dec 30, 2025

Merck: A Post-2028 Slowdown Doesn’t Kill The Long-Term Thesis (NYSE:MRK) - Seeking Alpha

Dec 30, 2025
pulisher
Dec 30, 2025

Oak Harvest Investment Services Purchases 24,325 Shares of Merck & Co., Inc. $MRK - MarketBeat

Dec 30, 2025
pulisher
Dec 30, 2025

Fort Washington Investment Advisors Inc. OH Has $51.42 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat

Dec 30, 2025
pulisher
Dec 30, 2025

Merck & Co., Inc. (NYSE:MRK) Hits New 1-Year HighHere's What Happened - MarketBeat

Dec 30, 2025
pulisher
Dec 30, 2025

Diversified Trust Co Purchases 18,187 Shares of Merck & Co., Inc. $MRK - MarketBeat

Dec 30, 2025
pulisher
Dec 30, 2025

Chemung Canal Trust Co. Buys 13,285 Shares of Merck & Co., Inc. $MRK - MarketBeat

Dec 30, 2025
pulisher
Dec 30, 2025

Farmers & Merchants Investments Inc. Cuts Stock Position in Merck & Co., Inc. $MRK - MarketBeat

Dec 30, 2025
pulisher
Dec 30, 2025

Merck & Co., Inc. (NYSE:MRK) S&P 500 ETF Scientific Infrastructure - Kalkine Media

Dec 30, 2025
pulisher
Dec 30, 2025

Where is Merck & Co. (MRK) Headed According to Wall Street? - Finviz

Dec 30, 2025
pulisher
Dec 29, 2025

November phase III successes led by HIV wins from Gilead, Merck - BioWorld MedTech

Dec 29, 2025
pulisher
Dec 29, 2025

Merck & Co Unusual Options Activity - Benzinga

Dec 29, 2025
pulisher
Dec 29, 2025

Norris Perne & French LLP MI Sells 36,819 Shares of Merck & Co., Inc. $MRK - MarketBeat

Dec 29, 2025
pulisher
Dec 29, 2025

Merck & Co., Inc. $MRK Shares Sold by Ethic Inc. - MarketBeat

Dec 29, 2025
pulisher
Dec 28, 2025

Merck (MRK) Stock Today: Latest News, Analyst Forecasts, and What Investors Should Watch Before Monday’s Open - ts2.tech

Dec 28, 2025
pulisher
Dec 28, 2025

Valley National Advisers Inc. Acquires 25,843 Shares of Merck & Co., Inc. $MRK - MarketBeat

Dec 28, 2025
pulisher
Dec 28, 2025

Institutional Investors Control 79% of Merck & Co., Inc. (NYSE:MRK) and Were Rewarded Last Week After Stock Increased 5.6% - 富途牛牛

Dec 28, 2025
pulisher
Dec 27, 2025

3 Drug Stocks to Buy at a Discount - The Motley Fool

Dec 27, 2025
pulisher
Dec 27, 2025

Merck (MRK) Stock Update: Weekend Wrap, Latest Headlines, Analyst Targets, and What to Watch Before Monday’s Open - ts2.tech

Dec 27, 2025
pulisher
Dec 27, 2025

Merck & Co., Inc. $MRK Stock Holdings Lowered by Kempner Capital Management Inc. - MarketBeat

Dec 27, 2025
pulisher
Dec 26, 2025

Merck & Co. Is Honored to Be Named to Forbes America's Best Employers List for the Eighth Year in a Row. - CSRwire

Dec 26, 2025
pulisher
Dec 26, 2025

Merck & Co. Named as a 2022 Best Place to Work for LGBTQ+ Equality - CSRwire

Dec 26, 2025
pulisher
Dec 26, 2025

Looking Into Merck & Co Inc's Recent Short Interest - Benzinga

Dec 26, 2025
pulisher
Dec 26, 2025

Highland Capital Management LLC Sells 34,848 Shares of Merck & Co., Inc. $MRK - MarketBeat

Dec 26, 2025
pulisher
Dec 26, 2025

Merck (MRK) is an inexpensive stock, says Jim Cramer - MSN

Dec 26, 2025
pulisher
Dec 26, 2025

Pacer Advisors Inc. Lowers Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat

Dec 26, 2025
pulisher
Dec 26, 2025

Secured Retirement Advisors LLC Raises Position in Merck & Co., Inc. $MRK - MarketBeat

Dec 26, 2025
pulisher
Dec 26, 2025

Cwm LLC Raises Holdings in Merck & Co., Inc. $MRK - MarketBeat

Dec 26, 2025
pulisher
Dec 26, 2025

Avanza Fonder AB Increases Stake in Merck & Co., Inc. $MRK - MarketBeat

Dec 26, 2025
pulisher
Dec 25, 2025

Merck (MRK) Stock: Key News, Analyst Targets, and Catalysts to Know Before the Market Opens Dec. 26, 2025 - ts2.tech

Dec 25, 2025
pulisher
Dec 25, 2025

Merck & Co. (MRK) Enters 2026 in the Spotlight: BMO Upgrade to $130, FDA Fast-Track Vouchers and TrumpRx Pricing Deal Reframe the Post-Keytruda Story - ts2.tech

Dec 25, 2025
pulisher
Dec 25, 2025

Merck (MRK) Stock News on Dec. 25, 2025: BMO Lifts Target to $130 as FDA Fast-Track Vouchers and Keytruda Data Fuel Momentum - ts2.tech

Dec 25, 2025
pulisher
Dec 25, 2025

Bar Harbor Wealth Management Buys 14,147 Shares of Merck & Co., Inc. $MRK - MarketBeat

Dec 25, 2025
pulisher
Dec 24, 2025

Merck & Co., Inc. (NYSE:MRK) Sets New 12-Month HighWhat's Next? - MarketBeat

Dec 24, 2025
pulisher
Dec 24, 2025

Vontobel Holding Ltd. Increases Holdings in Merck & Co., Inc. $MRK - MarketBeat

Dec 24, 2025
pulisher
Dec 24, 2025

Hanson & Doremus Investment Management Lowers Stock Position in Merck & Co., Inc. $MRK - MarketBeat

Dec 24, 2025
pulisher
Dec 24, 2025

Swedbank AB Grows Position in Merck & Co., Inc. $MRK - MarketBeat

Dec 24, 2025
pulisher
Dec 24, 2025

Merck & Co., Inc. $MRK Shares Sold by Farther Finance Advisors LLC - MarketBeat

Dec 24, 2025
pulisher
Dec 24, 2025

Exchange Traded Concepts LLC Has $7.99 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat

Dec 24, 2025
pulisher
Dec 24, 2025

Merck & Co., Inc (NYSE:MRK) S&P 500 Companies Biotech Footprint - Kalkine Media

Dec 24, 2025

Finanzdaten der Merck Co Inc-Aktie (MRK)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
drug_manufacturers_general NVS
$137.87
price down icon 0.61%
drug_manufacturers_general NVO
$50.88
price down icon 0.66%
$327.31
price down icon 0.42%
$122.74
price down icon 0.36%
drug_manufacturers_general PFE
$24.90
price down icon 0.36%
Kapitalisierung:     |  Volumen (24h):